Category: Clinical Breakthroughs
-
Standard Treatment May Not Benefit Many Patients With Mild Asthma
Many patients with mild asthma may not benefit from inhaled steroid medications, the current standard treatment, according to a clinical trial published in the New England Journal of Medicine.
-
Drug Improves Survival in Relapsed Chronic Lymphocytic Leukemia
A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
-
Drug Shows Benefit in Metastatic Osteosarcoma
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
-
Only Half of U.S. Kids and Teens Have Ideal Cholesterol Levels
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
-
Artificial Intelligence System Spots Lung Cancer Before Radiologists
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
-
Delaying Treatment for Diabetic Eye Condition Could Be Beneficial
Waiting to begin treatments for diabetic macular edema until patients experience vision loss resulted in similar outcomes compared to starting treatments prior to vision loss, according to a recent study published in JAMA.
-
Heart Failure Deaths Rising in Younger Adults
Death rates due to heart failure are now increasing, and this increase is most prominent among younger adults under 65, according to a new study.
-
Innovations in Radiology
In the Department of Radiology, collaboration is essential for translating discoveries from bench to bedside.
-
Visitor Restrictions Reduce Viral Respiratory Infections Among Hospitalized Children
Visitor restrictions during winter months were associated with a significant decrease in the transmission of viral respiratory infections among hospitalized children, according to a Northwestern study.
-
Mixed Results for New Lymphoma Therapy
A relatively newer and more complex therapy for diffuse large B-cell lymphoma did not show improvement over the current standard of care, but provides important new context for how the cancer affects treatment options.
